FR940902-2-00034 FR940902-2-00027 DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Scientific Misconduct AGENCY: Office of the Secretary, HHS. ACTION: Notice. SUMMARY: Notice is hereby given that the Office of Research Integrity (ORI) has made final findings of scientific misconduct in the following case: Pantelis Constantoulakis, Advanced BioScience Laboratories, Inc.: The Division of Research Investigations (DRI) of the Office of Research Integrity (ORI) reviewed an investigation conducted by Advanced BioScience Laboratories (ABL) into possible scientific misconduct on the part of Mr. Constantoulakis while an employee of ABL at the Frederick Cancer Research and Development Center. ORI concurred with the factual findings as set forth in the ABL report, and finds that Mr. Constantoulakis committed scientific misconduct by falsifying and fabricating data in biomedical research supported by a contract with the National Cancer Institute and by misrepresenting his academic credentials for purposes of his employment under the contract. Mr. Constantoulakis accepted the misconduct finding and agreed to a Voluntary Exclusion and Settlement Agreement under which Mr. Constantoulakis will not apply for Federal grant or contract funds and will not serve on PHS advisory committees, boards, or peer review groups for a five-year period beginning August 2, 1994. One published paper ( Science : 259:1314&hyph;1318) which contained data that was not reproducible has been retracted ( Science : 264:492). FOR FURTHER INFORMATION CONTACT: Director, Division of Research Investigations, Office of Research Integrity, 301&hyph;443&hyph;5330. Lyle W. Bivens, Director, Office of Research Integrity. [FR Doc. 94&hyph;21742 Filed 9&hyph;1&hyph;94; 8:45 am] BILLING CODE 4160&hyph;17&hyph;M
